Supporting the improvement and management of prescribing for urinary tract infections (SIMPle): protocol for a cluster randomized trial

Sinead Duane, Aoife Callan, Sandra Galvin, Andrew W Murphy, Christine Domegan, Eamon O'Shea, Martin Cormican, Kathleen Bennett, Martin O'Donnell, Akke Vellinga, Sinead Duane, Aoife Callan, Sandra Galvin, Andrew W Murphy, Christine Domegan, Eamon O'Shea, Martin Cormican, Kathleen Bennett, Martin O'Donnell, Akke Vellinga

Abstract

Background: The overuse of antimicrobials is recognized as the main selective pressure driving the emergence and spread of antimicrobial resistance in human bacterial pathogens. Urinary tract infections (UTIs) are among the most common infections presented in primary care and empirical antimicrobial treatment is currently recommended. Previous research has identified that a substantial proportion of Irish general practitioners (GPs) prescribe antimicrobials for UTIs that are not in accordance with the Guidelines for Antimicrobial Prescribing in Primary Care in Ireland. The aim of this trial is to design, implement and evaluate the effectiveness of a complex intervention on GP antimicrobial prescribing and adult (18 years of age and over) patients' antimicrobial consumption when presenting with a suspected UTI.

Methods/design: The Supporting the Improvement and Management of Prescribing for urinary tract infections (SIMPle) study is a three-armed intervention with practice-level randomization. Adult patients presenting with suspected UTIs in primary care will be included in the study.The intervention integrates components for both GPs and patients. For GPs the intervention includes interactive workshops, audit and feedback reports and automated electronic prompts summarizing recommended first-line antimicrobial treatment and, for one intervention arm, a recommendation to consider delayed antimicrobial treatment. For patients, multimedia applications and information leaflets are included. Thirty practices will be recruited to the study; laboratory data indicate that 2,038 patients will be prescribed an antimicrobial in the study. The primary outcome is a change in prescribing of first-line antimicrobials for UTIs in accordance with the Guidelines for Antimicrobial Prescribing in Primary Care in Ireland. The study will take place over 15 months with a six-month intervention period. Data will be collected through a remote electronic anonymized data-extraction system, a text-messaging system and GP and patient interviews and surveys. The intervention will be strengthened by the implementation of a social marketing framework and an economic evaluation.

Trial registration: This intervention is registered at ClinicalTrials.gov, ID NCT01913860.

Figures

Figure 1
Figure 1
Study design.

References

    1. Transatlantic Taskforce on Antimicrobial Resistance. Recommendations for Future Collaboration Between the U.S. and EU. Stockholm; 2011.
    1. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005;14 CD003539.
    1. Amyes S. The rise in bacterial resistance: is partly because there have been no new classes of antibiotics since the 1960s. BMJ. 2000;14:199. doi: 10.1136/bmj.320.7229.199.
    1. Murphy M, Byrne S, Bradley CP. Influence of patient payment on antibiotic prescribing in Irish general practice: a cohort study. Br J Gen Prac. 2011;14:e549–e555.
    1. Policy Group on Healthcare-Associated Infection (HCAI) Antibiotic Use and the Implications for Healthcare-Associated Infection) Dublin: Royal College of Physicians of Ireland; 2009.
    1. Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother. 2010;14:1514–1520. doi: 10.1093/jac/dkq149.
    1. National Disease Surveillence Centre Ireland. A Strategy for the Control of Antimicrobial Resistance in Ireland (SARI): Report of the Subgroup of the Scientific Advisory Committee of the National Disease Surveillance Centre. Dublin; 2001.
    1. Vellinga A, Cormican M, Hanahoe B, Bennet K. Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland. BMC Fam Prac. 2011;14:108. doi: 10.1186/1471-2296-12-108.
    1. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M. Antimicrobial resistance: is a major threat to public health. BMJ. 1998;14:609. doi: 10.1136/bmj.317.7159.609.
    1. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. 2002;14:347. doi: 10.3201/eid0804.010312.
    1. Carey B, Murphy M, Bradley C, Cunney R, Byrne S, O’Connor N, Sheehan A. Guidelines for Antimicrobial Prescribing in Primary Care in Ireland. Health Protection Surveillance Centre: Dublin; 2011.
    1. Vellinga A, Tansey S, Hanahoe B, Bennett K, Murphy AW, Cormican M. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. J Antimicrob Chemother. 2012;14:2523–2530. doi: 10.1093/jac/dks222.
    1. Bishop MC. Uncomplicated urinary tract infection. EAU Update Series. 2004;14:143–150. doi: 10.1016/j.euus.2004.08.003.
    1. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;14:653–660. doi: 10.1038/nrurol.2010.190.
    1. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;14:41–50. doi: 10.7326/0003-4819-135-1-200107030-00012.
    1. Vellinga A, Cormican M, Hanahoe B, Murphy AW. Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection. Br J Gen Prac. 2010;14:511. doi: 10.3399/bjgp10X514765.
    1. Mazulli T. Diagnosis and management of simple and complicated urinary tract infections (UTIs) Can J Urol. 2012;14:42–48.
    1. Huttner B, Goossens H, Verheij T, Harbarth S. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;14:17–31. doi: 10.1016/S1473-3099(09)70305-6.
    1. Fleming DM. The state of play in the battle against antimicrobial resistance: a general practitioner perspective. J Antimicrob Chemother. 2007;14:i49–i52. doi: 10.1093/jac/dkm157.
    1. Reynolds R. Antimicrobial resistance in the UK and Ireland. J Antimicrob Chemother. 2009;14:i19–i23. doi: 10.1093/jac/dkp257.
    1. Andrews T, Thompson M, Buckley DI, Heneghan C, Deyo R, Redmond N, Lucas PJ, Blair PS, Hay AD. Interventions to influence consulting and antibiotic use for acute respiratory tract infections in children: a systematic review and meta-analysis. PLoS One. 2012;14:e30334. doi: 10.1371/journal.pone.0030334.
    1. Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. Br J Gen Prac. 2003;14:871.
    1. Thoolen B, de Ridder D, van Lensvelt-Mulders G. Patient-oriented interventions to improve antibiotic prescribing practices in respiratory tract infections: a meta-analysis. Health Psychol Rev. 2012;14:92–112. doi: 10.1080/17437199.2011.552061.
    1. Duane S, Domegan C. Proceedings 'Taking Responsibility’: May 9 2–12; The Open University Milton Keynes. Stirling: Institute for Social Marketing; 2012. The commitment trust model of social marketing; pp. 43–47.
    1. McNulty CA, Boyle P, Nichols T, Clappison P, Davey P. The public's attitudes to and compliance with antibiotics. J Antimicrob Chemother. 2007;14:i63–i68. doi: 10.1093/jac/dkm161.
    1. The McDonnell Norms Group. Antibiotic overuse: the influence of social norms. J Am Coll Surg. 2008;14:265–275.
    1. Woodhead M, Finch R. Public education - a progress report. J Antimicrob Chemother. 2007;14:i53–i55. doi: 10.1093/jac/dkm158.
    1. Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education. JAMA. 1999;14:867–874. doi: 10.1001/jama.282.9.867.
    1. Forsetlund L, Bjørndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, Davis D, Odgaard-Jensen J, Oxman AD. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;14 CD003030.
    1. McNulty C. Optimising antibiotic prescribing in primary care. Int J Antimicrob Agents. 2001;14:329. doi: 10.1016/S0924-8579(01)00412-5.
    1. Santoso B, Suryawati S, Prawaitasari JE. Small group intervention vs formal seminar for improving appropriate drug use. Soc Sci Med. 1996;14:1163–1168. doi: 10.1016/0277-9536(95)00390-8.
    1. Bennett JW, Glasziou PP. Computerised reminders and feedback in medication management: a systematic review of randomised controlled trials. Med J Aus. 2003;14:217–222.
    1. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux P, Beyene J, Sam J, Haynes RB. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes. JAMA. 2005;14:1223–1238. doi: 10.1001/jama.293.10.1223.
    1. Martens JD, van der Aa A, Panis B, van der Weijden T, Winkens R, Severens JL. Design and evaluation of a computer reminder system to improve prescribing behaviour of GPs. Stud Health Technol Inform. 2006;14:617.
    1. Samore MH, Bateman K, Alder SC, Hannah E, Donnelly S, Stoddard GJ, Haddadin B, Rubin MA, Williamson J, Stults B. Clinical decision support and appropriateness of antimicrobial prescribing. JAMA. 2005;14:2305–2314. doi: 10.1001/jama.294.18.2305.
    1. Naughton C, Feely J, Bennett K. A RCT evaluating the effectiveness and cost effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing. J Eval Clin Pract. 2009;14:807–812. doi: 10.1111/j.1365-2753.2008.01099.x.
    1. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006;14:401–407. doi: 10.1093/jac/dkl188.
    1. Little P. Delayed prescribing of antibiotics for upper respiratory tract infection: with clear guidance to patients and parents it seems to be safe. BMJ. 2005;14:301. doi: 10.1136/bmj.331.7512.301.
    1. Sharland M, Kendall H, Yeates D, Randall A, Hughes G, Glasziou P, Mant D. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis. BMJ. 2005;14:328–329. doi: 10.1136/bmj.38503.706887.AE1.
    1. Christiaens T, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer J. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Prac. 2002;14:729.
    1. Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infec Dis. 2004;14:296–301. doi: 10.1080/00365540410019642.
    1. Little P, Moore M, Turner S, Rumsby K, Warner G, Lowes J, Smith H, Hawke C, Leydon G, Arscott A. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010;14:c199. doi: 10.1136/bmj.c199.
    1. Edwards M, Dennison J, Sedgwick P. Patients’ responses to delayed antibiotic prescription for acute upper respiratory tract infections. Br J Gen Prac. 2003;14:845.
    1. Høye S, Frich JC, Lindbæk M. Use and feasibility of delayed prescribing for respiratory tract infections: a questionnaire survey. BMC Fam Prac. 2011;14:34. doi: 10.1186/1471-2296-12-34.
    1. Leydon G, Turner S, Smith H, Little P. Women’s views about management and cause of urinary tract infection: qualitative interview study. BMJ. 2010;14:c279. doi: 10.1136/bmj.c279.
    1. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango) Soc Sci Med. 1997;14:681–692. doi: 10.1016/S0277-9536(96)00221-3.
    1. Légaré F, Labrecque M, Godin G, LeBlanc A, Laurier C, Grimshaw J, Castel J, Tremblay I, Frémont P, Cauchon M. Training family physicians and residents in family medicine in shared decision making to improve clinical decisions regarding the use of antibiotics for acute respiratory infections: protocol for a clustered randomized controlled trial. BMC Fam Prac. 2011;14:3. doi: 10.1186/1471-2296-12-3.
    1. Légaré F, Ratté S, Stacey D, Kryworuchko J, Gravel K, Graham ID, Turcotte S. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2010;14 CD006732.
    1. Gignon M, Idris H, Manaouil C, Ganry O. The waiting room: vector for health education? The general practitioner's point of view. BMC Res Notes. 2012;14:511. doi: 10.1186/1756-0500-5-511.
    1. McNulty CAM. European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibiotics through guidance, education and tools. J Antimicrob Chemother. 2012;14:2543–2546. doi: 10.1093/jac/dks358.
    1. Assathiany R, Kemeny J, Sznajder M, Hummel M, Van Egroo L, Chevallier B. The pediatrician’s waiting room: a place for health education? Arch Pediatr. 2005;14:10. doi: 10.1016/j.arcped.2004.07.026.
    1. Papa LM, Seaberg DC, Rees E, Ferguson K, Stair R, Goldfeder B, Meurer D. Does a waiting room video about what to expect during an emergency department visit improve patient satisfaction? CJEM. 2008;14:347–354.
    1. Gerber BS, Brodsky IG, Lawless KA, Smolin LI, Arozullah AM, Smith EV, Berbaum ML, Heckerling PS, Eiser AR. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Diabetes Care. 2005;14:1574–1580. doi: 10.2337/diacare.28.7.1574.
    1. Khan MA, Shah S, Grudzien A, Onyejekwe N, Banskota P, Karim S, Jin J, Kim Y, Gerber BS. A diabetes education multimedia program in the waiting room setting. Diabetes Ther. 2011;14:178–188. doi: 10.1007/s13300-011-0007-y.
    1. Eubelen C, Brendel F, Belche J-L, Freyens A, Vanbelle S, Giet D. Effect of an audiovisual message for tetanus booster vaccination broadcast in the waiting room. BMC Fam Prac. 2011;14:104. doi: 10.1186/1471-2296-12-104.
    1. Suffoletto B, Calabria J, Ross A, Callaway C, Yealy DM. A mobile phone text message program to measure oral antibiotic use and provide feedback on adherence to patients discharged from the emergency department. Acad Emerg Med. 2012;14:949–958. doi: 10.1111/j.1553-2712.2012.01411.x.
    1. Kotler P, Zaltman G. Social marketing: an approach to planned social change. J Marketing. 1971;14:3–12.
    1. McKenzie-Mohr D. Fostering sustainable behavior through community-based social marketing. Am Psychol. 2000;14:531.
    1. Gordon R, McDermott L, Stead M, Angus K. The effectiveness of social marketing interventions for health improvement: what’s the evidence? Public Health. 2006;14:1133–1139. doi: 10.1016/j.puhe.2006.10.008.
    1. Dahl S. Current themes in social marketing research: text-mining the past five years. Soc Mark Q. 2010;14:128–136. doi: 10.1080/15245001003746790.
    1. Hastings G. Relational paradigms in social marketing. J Macromarketing. 2003;14:6–15. doi: 10.1177/0276146703023001006.
    1. Niblett GR. Stretching the limits of social marketing partnerships, upstream and downstream: setting the context for the 10th innovations in social marketing conference. Soc Mark Q. 2005;14:9–15. doi: 10.1080/15245000500308898.
    1. Peattie S, Peattie K. Ready to fly solo? Reducing social marketing’s dependence on commercial marketing theory. Marketing Theory. 2003;14:365–385. doi: 10.1177/147059310333006.
    1. Hastings G, Domegan C. Social Marketing: From Tunes to Symphonies. 2. Abingdon: Routledge; 2013.
    1. French SD, Green S, O'Connor D, McKenzie JE, Francis JJ, Michie S, Buchbinder R, Schattner P, Spike N, Grimshaw JM. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implement Sci. 2012;14:38. doi: 10.1186/1748-5908-7-38.
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;14:38–48. doi: 10.4278/0890-1171-12.1.38.
    1. Howard JA, Sheth JN. The Theory of Buyer Behavior. New York: Wiley; 1969.
    1. Andreasen AR. Marketing Social Change: Changing Behaviour to Promote, Health, Social Development, and the Environment. San Francisco: Jossey-Bass; 1995.
    1. Irish Primary Care Research Network. [ ]
    1. McGowan B, Bennett K, Casey M, Doherty J, Silke C, Whelan B. Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008. Ir J Med Sci. 2013;14:601–608. doi: 10.1007/s11845-013-0935-9.
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG. CONSORT 2010 statement: extension to cluster randomised trials. BMJ. 2012;14:e5661. doi: 10.1136/bmj.e5661.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel